微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 93.88% | 8.13% | -0.59% | 4/159 | 50.16% | 迪哲医药 | 99.22% | 行业排名> |
| 2026-06-30 | 94.44% | 8.52% | -1.8% | 5/159 | 48.66% | 海创药业 | 97.34% | 行业排名> |
| 2026-03-31 | 96.17% | 11.97% | 11.13% | 3/159 | 50.28% | 海创药业 | 99.82% | 行业排名> |
| 2025-12-31 | 86.54% | -11.4% | -0.32% | 13/159 | 50.37% | 海创药业 | 98.62% | 行业排名> |
| 2025-09-30 | 86.82% | 37.17% | -0.23% | 11/159 | -2.13% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 87.02% | 51.28% | 1.32% | 8/159 | 15.05% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 85.89% | 62.05% | -12.06% | 8/159 | 31.79% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 97.68% | 163.81% | 54.31% | 2/159 | 51.61% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 63.3% | 133.36% | 10.03% | 43/159 | 22.43% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 57.53% | 127.43% | 8.53% | 60/159 | 32.96% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 53% | 2% | 134.63% | 68/159 | 51.47% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | -153.06% | 2% | 19.32% | 148/159 | 51.31% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | -189.72% | 2% | 9.52% | 145/159 | 32.31% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | -209.69% | 2% | 2% | 145/159 | 38.22% | 迈威生物 | 99.8% | 行业排名> |